CNX ANTIGEN-BINDING MOLECULES Application WO-2024008960-A1 World Intellectual Property Organisation (WIPO) 11 Jan 2024
CNX/ERP57 INHIBITOR FOR USE IN THE TREATMENT OR PREVENTION OF CANCER Application EP-3917571-A4 European Patent Office 12 Oct 2022
BIOMARKERS TO DETECT AND CHARACTERISE CANCER Application EP-3692371-A4 European Patent Office 09 Jun 2021
CNX/ERP57 INHIBITOR FOR USE IN THE TREATMENT OR PREVENTION OF CANCER Application WO-2020159445-A1 World Intellectual Property Organisation (WIPO) 06 Aug 2020